Responsiveness to change and English language validation of the WPAI-GERD questionnaire - results from a Canadian study Wahlqvist P 1, Guyatt G 2, Armstrong.

Slides:



Advertisements
Similar presentations
Standardized Scales.
Advertisements

ASSESSING RESPONSIVENESS OF HEALTH MEASUREMENTS. Link validity & reliability testing to purpose of the measure Some examples: In a diagnostic instrument,
VALIDITY AND RELIABILITY
Purpose Dimensional versus Dichotomous Scoring: A Meta-analytical Review of Personality Disorder Stability James B. Hoelzle, B.S., Erin M. Guell, B.A.,
PROMIS: The Right Place at the Right Time? David Cella, Ph.D. Department of Medical Social Sciences Northwestern University Chair, PROMIS Steering Committee.
Development and initial validation of the ‘Bristol Impact of Hypermobility’ (BIoH) questionnaire ST Palmer a, F Cramp a, R Lewis b, G Gould c, E Clark.
Figure 1. Higher prevalence of significant GER symptoms in patients with COPD. The prevalence of significant GER symptoms (heartburn and/or regurgitation.
Journal Club Alcohol and Health: Current Evidence March-April 2007.
Chapter 13 Survey Designs
Journal Club Alcohol and Health: Current Evidence July-August 2006.
Common Problems in Writing Statistical Plan of Clinical Trial Protocol Liying XU CCTER CUHK.
Cross-Cultural Use of Measurements: Development of the Chinese SF-36 Health Survey Xinhua S. Ren, Ph.D. Boston University School of Public Health, Boston,
A quick introduction to the analysis of questionnaire data John Richardson.
Quantitative Research
CORRELATIO NAL RESEARCH METHOD. The researcher wanted to determine if there is a significant relationship between the nursing personnel characteristics.
Comorbidity in SLE Compared with Rheumatoid Arthritis and Non-inflammatory Disorders Frederick Wolfe 1, Kaleb Michaud 1,2, Tracy Li 3, Robert S. Katz 4.
PhD Research Seminar Series: Reliability and Validity in Tests and Measures Dr. K. A. Korb University of Jos.
Presented By: Trish Gann, LPC
Pfizer Global Research & Development Sandwich CT13 9NJ Kent Introduction Sildenafil (Viagra  ) is an orally active, selective inhibitor of cGMP specific.
FDA Approach to Review of Outcome Measures for Drug Approval and Labeling: Content Validity Initiative on Methods, Measurement, and Pain Assessment in.
Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice Dea Kehler.
MEASUREMENT: VALIDITY Lu Ann Aday, Ph.D. The University of Texas School of Public Health.
Quality of Life in People with and at Risk for Type 2 Diabetes: Findings from the Study to Help Improve Early Evaluation and Management of Risk Factors.
Introduction Patients with tumors affecting the spine have significant impairments in Quality of Life domains that include physical function, neural function,
Fibromyalgia Patients Reading Self-Help Journals and in Internet Self-Help Groups: Are They Different from Patients in Clinical Practice? Robert Katz 1,
Use of Health-Related Quality of Life Measures to Assess Individual Patients July 24, 2014 (1:00 – 2:00 PDT) Kaiser Permanente Methods Webinar Series Ron.
Exploring the SF-36, V2: Measuring the Quality of Life of AgrAbility Program Participants Ronald C. Jester Robert A. Wilson University of Delaware National.
Purpose The present study examined the psychometric properties of the SCARED in order to begin establishing an evidence base for using the SCARED in pediatric.
This Outcome Report is based on data from patients who completed a Functional Restoration Programme (FRP) at the RealHealth Treatment Centre in Coventry.
Lecture 6: Reliability and validity of scales (cont) 1. In relation to scales, define the following terms: - Content validity - Criterion validity (concurrent.
Quality Of Life, Health And Well Being Of Highly Active Individuals Louisa Raisbeck, Jeanne Johnston, Joel Stager, Francoise Benay Human Performance Laboratory,
1 Assessing the Minimally Important Difference in Health-Related Quality of Life Scores Ron D. Hays, Ph.D. UCLA Department of Medicine October 25, 2006,
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
The Health and Wellbeing Study: An Investigation into the Perceived Health and Wellbeing of Irish Adults Living with Asthma in Ireland Dr Mary Hughes,
Introduction to the Patient-Reported Outcomes Measurement Information System (PROMIS) UCLA Center for East-West Medicine 2428 Santa Monica Blvd., Suite.
Interpersonal Skills 4 detailed studies Health Psychology.
Measuring Health-Related Quality of Life
Impact on work productivity of upper gastrointestinal symptoms associated with chronic NSAID therapy in a Swedish study population Wahlqvist P, Bergenheim.
The reliability of the Minimum European Health Module TF-HE 3/12/2007 Bianca Cox Herman van Oyen.
1 Session 6 Minimally Important Differences Dave Cella Dennis Revicki Jeff Sloan David Feeny Ron Hays.
Presented By Dr / Said Said Elshama  Distinguish between validity and reliability.  Describe different evidences of validity.  Describe methods of.
SOCW 671: #5 Measurement Levels, Reliability, Validity, & Classic Measurement Theory.
EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematosus: Comparisons with RA, Non-Inflammatory Disorders (NIRD), and Fibromyalgia (FM)
Tiago Lansini, MD ; Sergio Kwitko, PhD Authors have no financial interest in the subject matter of this poster.
1 Impact of Implementing Designed Nursing Intervention Protocol on Clinical Outcome of Patient with Peptic Ulcer By Amal Mohamed Ahmad Assistant Professor,
Reliability and validity of the adapted Spanish version of the Early Onset Scoliosis-24 questionnaire María del Mar Pozo-Balado, PhD Hiroko Matsumoto PhD.
Reliability and Validity of the Intensive Care Delirium Screening Checklist in Turkish Gulsah Kose, Abdullah Bolu, Leyla Ozdemir, Cengizhan Acikel, Sevgi.
WINKS 7 Tutorial 3 Analyzing Summary Data (Using Student’s t-test) Permission granted for use for instruction and for personal use. ©
Quality of Life (QOL) & Patient Reported Outcomes (PRO) Lori Minasian, MD Chief, Community Oncology and Prevention Trials Research Group, DCP, NCI, NIH,
Practice Key Driver Diagram. Chapter Quality Network ADHD Project Jeff Epstein PhD CQN ADHD National Expert/CQN Data Analyst The mehealth Portal and CQN.
Measurement of Outcomes Ron D. Hays Accelerating eXcellence In translational Science (AXIS) January 17, 2013 (2:00-3:00 pm) 1720 E. 120 th Street, L.A.,
Principles of Assessment and Outcome Measurement for Physical Therapists ksu. edu. sa Dr. taher _ yahoo. com Mohammed TA, Omar,
Quantitative research Meeting 7. Research method is the most concrete and specific part of the proposal.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Quality of Life After Treatment of Laryngeal.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Implantable Cardioverter Defibrillators and Quality.
PHARMAECONOMICS Pulmonary Arterial Hypertension Nelli ÄIJÖ & Feyza Nur POLAT Nika Marđetko.
Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy CHRISTINA REIMER, BO SØNDERGAARD, LINDA HILSTED,
Differences in Fatigue and Depressive Symptoms Between Long and Average Sleeping Older Adults Introduction Methods Results Discussion Support Major Depressive.
The Impact of Lifestyle Modification on the Health-Related Quality of Life of Patients With Reflux Esophagitis Receiving Treatment With a Proton Pump Inhibitor.
A2 unit 4 Clinical Psychology 4) Content Reliability of the diagnosis of mental disorders Validity of the diagnosis of mental disorders Cultural issues.
Table 1. Characteristics of the study population in 1997 and Table 2. Logistic regression to assess the predictive value of (pre)frailty for poor.
Health Related Quality of Life after serious occupational injuries and long term disability Presenter: Ibishi Nazmie MD,PhD University Clinical Center.
Sofija Zagarins1, PhD, Garry Welch1, PhD, Jane Garb2, MS
Fibromyalgia Impact Questionnaire McGill Pain Questionnaire
When Using DOPPS Slides
Patient Baseline Assessment
By Dr Shewikar Farrag Dr Nehad Sabry
Reliability & Validity
Seth D. Crockett, Quinn K. Lippmann, Evan S. Dellon, Nicholas J
Evaluating the Significance of Individual Change
Presentation transcript:

Responsiveness to change and English language validation of the WPAI-GERD questionnaire - results from a Canadian study Wahlqvist P 1, Guyatt G 2, Armstrong D 2, Austin P 2, Barkun A 3, Chiba N 2, degl'Innocenti A 1, El-Dika S 4, Fallone C 3, Heels-Ansdell D 2, Tanser L 5, Veldhuyzen van Zanten S 6, Wiklund I 1, Schünemann H 4 1 AstraZeneca R&D Mölndal, Sweden; 2 McMaster University, Hamilton, ON, Canada; 3 McGill University Health Centre, Montreal, QC, Canada; 4 University at Buffalo, Buffalo, NY, USA; 5 AstraZeneca Canada, Mississauga, ON, Canada; 6 Dalhousie University, Halifax, NS, Canada Results from the effect size calculations are shown in Table 4. Results indicate moderate responsiveness of each productivity variable, except for GERD-related absence from work where the effect size indicates a small responsiveness. Further, the large and statistically significant changes after treatment reported in Table 1 are in themselves indicators of responsive- ness of all relevant productivity variables. C ONCLUSIONS Cross-sectional construct validity of the English WPAI-GERD version was confirmed and results indicated that the WPAI-GERD is responsive to change. Although these results also indicated poor longitudinal construct validity, the overall findings suggest that further study of the instrument remains warranted. O BJECTIVES Cross-sectional construct validity of the Work Productivity and Activity Impairment questionnaire for Gastro-Esophageal Reflux Disease (WPAI- GERD) has previously been established in a study of Swedish patients consulting a general practitioner because of GERD symptoms. 1 The purpose of this study was to assess cross-sectional and longitudinal construct validity of the English language version, as well as responsiveness to change of the WPAI-GERD. M ETHODS The WPAI-GERD was used in a clinical study in Canadian GERD patients with moderate or severe symptoms treated with esomeprazole 40 mg once daily for 4 weeks. 2 Productivity variables obtained included GERD-specific hours absence from work, percent of reduced productivity while at work, and percent of reduced productivity while carrying out regular daily activities other than work during the preceding week. Before starting treatment, patients completed the Medical Outcomes Short Form 36 (SF-36) questionnaire 3 for assessing their health status during the past week. The SF-36 covers 8 dimensions: Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role- Emotional and Mental Health. Before (at baseline) and after treatment (at follow-up), patients also completed the following questionnaires, all using a one-week recall period: Quality of Life in Reflux and Dyspepsia (QOLRAD), 4 a GERD-specific health-related quality of life questionnaire with 25 items that combine into 5 dimensions: Sleep disturbance, Food and drink problems, Emotional distress, Vitality, and Physical/social functioning. A questionnaire for assessing severity of four symptoms (Heartburn, Acid reflux, Stomach ache, Belching) using a 7-point Likert scale. A questionnaire for assessing severity of overall stomach problems using a 7-point Likert scale. Cross-sectional validity refers to a validity assessment made at one measured time point, and longitudinal validity refers to a validity assessment made with regard to a change between two measurements. Evidence of construct validity was in the present study defined as: A statistically significant (p<0.05, adjusted for multiplicity) and sufficiently high correlation coefficient (preferably ≥ 0.30 for absence from work and ≥ 0.40 for other productivity variables) between each productivity variable and other variables where expected. 1 Responsiveness to change refers to the extent to which an instrument can accurately measure change in a subject’s condition over time. Responsiveness was assessed by calculating the effect size (mean change divided by the standard deviation at baseline) for each productivity variable. An effect size between was defined as small, between as moderate, and >0.8 as large. 5 R ESULTS The analysis included 217 patients, of whom 71% (n=153) were employed. Results obtained from the WPAI-GERD during the study period are shown in Table 1. The improvement (difference from start of treatment) in productivity per patient and week was 0.6 hours for absence from work, 11.0% units for reduced work productivity (=4.7 hours equivalent) and 16.1% units for reduced productivity in daily activities other than work due to GERD symptoms. This improvement translates into an avoided loss of work productivity of 5.3 hours in total ( ) on a weekly basis per patient employed. Table 1. WPAI-GERD results at baseline, at follow-up and change between baseline and follow-up. N BaselineFollow-upChange Mean95% CIMean95% CIMeanp-value Hours absence from work due to GERD (0.4, 1.3)0.3(0.1, 0.5) Hours actually worked (37.5, 42.0)40.0(37.6, 42.5) Percent reduced productivity, work (11.0, 17.0)3.0(1.8, 4.2)-11.0<0.001 Hours lost, reduced productivity, work*1265.8(4.5, 7.1)1.1(0.6, 1.6)-4.7<0.001 Percent reduced productivity, activities (17.9, 24.0)4.9(3.4, 6.3)-16.1<0.001 * Hours lost due to reduced productivity while at work = number of hours actually worked multiplied by percent of reduced productivity. Abbreviations: CI = Confidence Interval. A matrix of baseline, follow-up and change score correlations between productivity variables and other study variables relevant for validation purposes are shown in Table 2. Cross-sectional correlations (i.e. at baseline or follow-up) were all in the right direction and in accordance with expectations in general. 1 For example, the highest correlation with productivity variables would be expected to be with the QOLRAD dimension “Physical/social functioning”, which contains specific questions on the impact of GERD symptoms on work and daily activities. Overall, results support cross-sectional construct validity of the English WPAI-GERD. Change score correlations with QOLRAD dimensions were also according to expectations in general, with a high correlation between productivity and the “Physical/social functioning” dimension. However, change score correlations between productivity variables and symptom assessments were low, and these results do not support longitudinal construct validity of the WPAI-GERD. Table 2. Correlations between productivity variables and other study variables at baseline, at follow-up and change between baseline and follow-up, Pearson correlation coefficients. Hours absence from work, Reduced productivity, Hours lost, reduced productivity, Reduced productivity, GERD (N=139)work (N=130)work (N=126)activities (N=215) BaselineFollow-upChangeBaselineFollow-upChangeBaselineFollow-upChangeBaselineFollow-upChange SF-36 dimensions: Physical Functioning *--0.38*--0.49*-- Role-Physical0.40*--0.54*--0.49*--0.56*-- Bodily Pain *--0.49*--0.54*-- General Health * *-- Vitality *--0.36*--0.47*-- Social Functioning0.38*--0.54*--0.50*--0.59*-- Role-Emotional0.34*--0.43*--0.39*--0.52*-- Mental Health *--0.32*--0.43*-- QOLRAD dimensions: Emotional distress0.33* * 0.47*0.62*0.34* 0.43*0.57*0.32* 0.49*0.51*0.39* Sleep disturbance0.35* *0.56* * *0.46*0.28* Food/drink problem0.33*0.30* *0.50* *0.46* *0.45*0.34* Physical/social functioning0.38* * 0.52*0.62*0.46* 0.50*0.55*0.45* 0.63*0.53*0.56* Vitality0.43* * 0.52*0.65*0.39* 0.47*0.59*0.37* 0.57*0.54*0.42* Symptom severity: Stomach pain *0.43* * *0.44*0.20 Heartburn * * *0.29*0.21 Belching * * *0.11 Acid reflux * * *0.41*0.23* Overall symptoms * * *0.59*0.17 * Statistically significant (  =0.05), p-values adjusted for multiplicity (Bonferroni) at each measurement time point: p< at baseline, p< at follow-up and for change. Changes in each productivity variable between baseline and follow-up by change in heartburn severity are displayed in Table 3. In patients with a large or moderate change in symptoms, mean values indicate that a change in productivity is related to the magnitude of change in symptom severity, which in turn would indicate longitudinal construct validity. However, results also suggest that the insufficiently low change score correlations found between productivity and symptoms are mainly caused by; (1) high variability in productivity changes between individual responses, and (2) patients with a small or no change in symptoms also reporting an improvement in productivity. Table 3. WPAI-GERD results, change between baseline and follow-up by change in heartburn symptom severity. Improvement in heartburn Change in hours absence Change in percent reduced Change in hours lost, Change in percent reduced symptom severity # from work, GERD productivity, work reduced productivity, work productivity, activities NMean (SD)NMean (SD)NMean (SD)NMean (SD) +5 or (4.5) (24.2) (9.3) (23.5) (3.0) (15.7) (9.3) (20.7) (0.6) (14.7) (5.6) (19.9) (1.9) (7.6) (3.3) (17.6) +1 or no improvement (2.0) (17.3) (6.4) (19.9) # Number of units improvement between baseline and follow-up in the 7-graded heartburn symptom severity scale. Abbreviations: SD = Standard Deviation. Table 4. Effect size calculations. NMean95% CI Hours absence from work, GERD (0.05, 0.38) Percent reduced productivity, work (0.47, 0.81) Hours lost, reduced productivity, work (0.47, 0.81) Percent reduced productivity, activities (0.59, 0.84) Abbreviations: CI = Confidence Interval. R EFERENCES 1. Wahlqvist P, Carlsson J, St å lhammar N-O, Wiklund I. Validity of a Work Productivity and Activity Impairment Questionnaire for Patients with Symptoms of Gastro- Esophageal Reflux Disease (WPAI-GERD) - Results From a Cross-Sectional Study. Value in Health 2002;5: Schunemann HJ. A randomized multi-center trial to compare utility elicitation techniques with and without hypothetical health states. Quality of Life Research 2003;12(7):A Ware JE, Snow KK, Kosinski MA. SF-36 Health Survey Manual and Interpretation Guide. Boston, Massachusetts: New England Medical Centre, Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. American Journal of Gastroenterology 2001; 96: Cohen J. Statistical power analysis for the behavioral sciences. New York: Academy Press, 1977.